charantin (6) and momordicoside K (7) were isolated from the green fruits of Momordica charantia. The (S)-epimers of 1 and 2 are the first reports in nature. The acetyl-and butyryl-cholinesterase inhibitory activities of the isolated compounds were evaluated, and 5 showed the highest activity of these compounds against butyrylcholinesterase (IC 50 = 32.20 μM) with a reversible and non-competitive inhibition mode.
The bitter gourd, Momordica charantia L., a vine in the family Cucurbitaceae, is a vegetable and medicinal plant that originated on the Indian subcontinent and is now widely distributed in tropical and subtropical countries including several regions of Thailand [1] . Two botanical varieties of M. charantia are found in Thailand. The first is a cultivated form with a large light-green fruit (M. charantia var. charantia) called Chinese bitter gourd, while the other is a wild form with a small dark-green fruit (var. muricata) known as Thai bitter gourd or Mara Khee Nok. The latter variety is mostly used in folklore Thai medicine as a laxative and anti-helmintic, anti-ulcer and anti-inflammatory herb [2] . In addition, it is commonly eaten as a side-dish vegetable with chili paste. Solvent extracts of M. charantia, especially the immature fruits and leaves, have been reported to possess anti-carcinogenic, chemopreventive [3, 4] and anti-oxidant [5] activities. Studies on the phytochemical constituents of M. charantia have been carried out since 1950 and have led to the isolation of many classes of natural compounds (e.g. triterpenes, steroids, glycosides, saponins, proteins and phenolic compounds). More than 50 cucurbitane-type triterpenes so far have been obtained from most parts of this plant [6] . Moreover, a variety of biological activities, such as α-glucosidase inhibitory [7] , antioxidant [8] , anti-diabetic [9] , anti-HIV [10] and anti-cancer [11] [12] [13] [14] potencies, of the isolated chemicals from this plant have been reported.
Alzheimer's disease (AD) is the leading cause of dementia in the elderly population and is related to an insufficient local level of the neurotransmitter acetylcholine (ACh) in the brain. Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), which are responsible for the inactivation of ACh at the synaptic gap by hydrolysis, is widely used in the symptomatic treatment for AD patients [15] . Many natural products and synthetic cholinesterase inhibitors (ChEIs), which are approved for AD treatment, are alkaloids, such as tacrine, eserine, galantamine, rivastigmine and donepezil. They can be selective for inhibition of either AChE or BChE or broader and inhibit both. However, they can generate violent adverse effects, such as nausea, vomiting, anorexia, diarrhea, headache, muscle cramping and weakness in patients [16] . Therefore, other classes of ChEIs from nature and non-alkaloid based compounds, such as triterpenoids, xanthones and coumarins, are new interesting alternatives. Our interest in Mara Khee Nok (M. charantia) was raised when we carried out a preliminary ChEI activity screening of Thai edible and non-alkaloid plants. The methanolic extract of M. charantia showed many clear spots of BChEI activity, but less for AChEI activity, on a resolved thin layer chromatography (TLC) plate using the bio-autographic method. However, the inhibition activity of this extract using the microplate assay could not be determined due to the dark green color and low solubility of the extract under the assay condition.
The green fruits of M. charantia var. muricata were extracted and chromatographically fractionated. The structures of the isolated compounds were determined by spectroscopic techniques and comparison with the relevant published data. Mixtures 1 and 2 were identified as mixtures of cucurbitane triterpenoid epimers. Although 1a and 2a were already known [17] [18] [19] , their respective C-19 epimers (1b and 2b) were characterized in this study for the first time. The structures of the other isolated compounds were known and clearly elucidated as 5β,19-epoxy-19(R)-methoxycucurbita-6,23,25-trien-3β-ol (3) [20] , 5β,19-epoxycucurbita-6,23-diene-3β,25-diol (4) [21] , ligballinol (5) [22, 23] , charantin as a mixture of sitosteryl glucoside (6a) and stigmasteryl glucoside (6b) [24] , and momordicoside K (7) [25] (Figure 1 ). Among them, ligballinol (5) was isolated for the first time from M. charantia.
The inseparable mixture 1 was obtained as a colorless prism. The HPLC analysis showed two separable peaks with a peak area ratio of approximately 2:1 but they could isomerize resulting in inseparable components. The HRESI-MS data of 1 showed a pseudomolecular ion peak at 477.3225 [M+Na] + consistent with the molecular formula C 30 H 46 O 3 . The elucidation of the major signals from the NMR spectral data of 1 (Table 1) indicated that they were similar to those of 3 [20] , with the only difference being due to the presence of a hydroxyl group at C-19 in 1 replacing the methoxyl group at C-19 in 3. The oxymethine signals at  H 5.13 and 4.88, which correlated in the HSQC spectrum with the CH at  C 105.4 Luckily, this mixture could be re-crystallized as a colorless prism from MeOH and further determined by X-ray crystallographic analysis. The ORTEP plot ( Figure 2 ) indicated that this mixture was composed of C-19 epimers with the doubly disordered hydroxyl group O-3−H over sites A and B, having occupancy factors of 64% and 36%, respectively. However, the major component (1b) in the solid state as evidenced from the X-ray crystallographic result was switched from that obtained by the NMR data.
Mixture 2, obtained as white needles, was a mixture of C-19 epimers, with a ratio of about 2:1, as determined by the HPLC peak area. Its molecular formula was deduced to be C 31 H 50 O 4 on the basis of the positive HRESI-MS which showed an ion peak at m/z 509.3421 [M+Na] + . Careful analysis of the 1 H and 13 C NMR spectral data of 2 and 1 (Table 1) made it clear that these two components were similar except for the side chain moiety. The signals due to the C-25, C26 exo-double bond in 1 was absent, but a methyl, a methoxyl and an oxygenated quaternary carbon were observed in 2 by resonances at δ C 25.8, 50.2 and 74.9, respectively. These results established that the side chain moiety of 2 was the same as that of momordicoside K (or 7 in this study).
correlations as that of 1 in which the NOESY cross-peak between H-19 ( H 4.87) and H-8 ( H 2.22, m) of the minor epimer (2b) indicating the (S)-configuration. Based on these data, 2 was a mixture of C-19 epimers and composed of the major 5,19-epoxy-25-methoxy-cucurbita-6,23-diene-3,19(R)-diol (2a) and minor 5,19-epoxy-25-methoxy-cucurbita-6,23-diene-3,19(S)-diol (2b) compounds. The former (2b) is the first report as a natural product whilst the latter (2a) has previously been isolated from M. foetida and M. charantia [18, 19] . The apparent AChEI and BChEI activities of the isolated compounds from M. charantia are shown in Figure 3 . At a final concentration of 0.05, 0.1 and 0.5 mg/mL, all seven tested compounds/mixtures showed a weak AChEI activity compared to those of the standard inhibitor, eserine. The most active of the test compounds was 7 which exhibited 50% inhibition at 0.5 mg/mL. In the same way, all of the test compounds, except for 5, were considered as having an ineffective BChEI activity (< 40% even at 0.5 mg/mL). However, compound 5 inhibited BChE in a dosedependent manner with an IC 50 for the BChEI activity of 32.2  0.2 μM, which was 15.6-and 6.5-fold higher than that of eserine (2.1  0.1 μM) and galantamine (4.9  0.6 μM), respectively. The IC 50 values of the other test compounds for BChE, or any for AChE, were not evaluated due to their low activity and insufficient solubility under the assay condition. The BChEI mode of 5 was investigated by recording the substrate-velocity curves in the presence of varying concentrations of 5 and analyzing the resultant Lineweaver-Burk plots (Figure 4) . These plots revealed no change to the K m values (the negative reciprocal of the X-intercept), whilst the ν max was increased from 0.38 to 0.70 µM by the addition of 5. This result indicated a reversible and non-competitive inhibition of BChE by 5, and so 5 does not compete for the same active site as the substrate.
In this study, the major composition of M. charantia extracts that exhibited AChEI and BChEI activities (albeit weak) were cucurbitane triterpenoids. This is in contrast to the preliminary BChEI activity results in which the M. charantia extract showed many inhibitory spots on a TLC bio-autographic plate. This apparent discrepancy might be due to the interaction of multiple components in each spot (combination or synergistic) or that the potent compounds were not obtained as they are labile or relatively rare. However, ligballinol (5) was obtained as a minor component but showed a relatively high activity. According to previous studies, not many lignans have been reported to exhibit ChEI activity. Schisandrin and syringaresinol showed AChEI activity in vivo [26] and in vitro [27] , respectively, and a moderate BChEI activity was found in 3'demethylisolariciresinol-9'-hydroxyisopropylether [28] . Although ligballinol is known to be found in many plants, its bioactivities have rarely been reported.
In conclusion, two new compounds, 1b and 2b, in the forms of epimers were isolated from M. charantia fruits. Most of the isolated compounds exhibited only a low to weak AChEI and BChEI activity, except for ligballinol (5) that showed the highest BChEI activity with an IC 50 value of 32.2 μM. Although this activity was not in the same range as the clinical drugs, eserine and galantamine, the simply core structure of this compound may be interesting to modify and further study the structure activity relationships.
Experimental

Plant materials:
The unripe fruits of M. charantia were collected from Phetchaburi Province, Thailand in January 2011 and indentified by Assoc. Prof. Nijsiri Ruangrungsi, Faculty of Pharmaceutical Sciences, Chulalongkorn University. A voucher specimen of this plant material (No. NPRU 0003) has been deposited in the laboratory at Natural Products Research Unit, Department of Chemistry, Faculty of Science, Chulalongkorn University, Thailand.
Extraction and isolation:
The air-dried fruits of M. charantia var. muricata (2.5 kg) were extracted with methanol (MeOH; 3  500 mL), the methanolic extracts pooled and concentrated in vacuo to obtain the crude MeOH extract. This extract was further partitioned sequentially with n-hexane, dichloromethane (CH 2 Cl 2 ) and watersaturated butanol (BuOH), and the respective solvent removed by evaporation to yield the n-hexane (18.8 g), CH 2 Cl 2 (102.9 g) and BuOH (54.7 g) extracts.
A portion of the CH 2 Cl 2 extract (83.9 g) was subjected to a vacuum silica gel column chromatography and eluted by a n-hexane:ethyl acetate (EtOAc) gradient (100:0 to 0:100 (v/v)) and then a EtOAc:MeOH gradient (100:0 to 80:20 (v/v)). Each fraction was monitored for ChEI activity by TLC analysis and gave eight fractions (MD1 to MD8). Fraction MD2 was separated on a silica gel column, using a stepwise n-hexane:EtOAc (80:20 to 0:100 (v/v)) gradient to give six sub-fractions (MD2-1 to MD2-6). Recrystallization of fraction MD2-1 by the binary system of CH 2 Cl 2 and MeOH gave 3 (45.5 mg). Fraction MD2-3 was purified by a silica gel column (9:1 (v/v) n-hexane:acetone as the eluent) to yield 4 (35.4 mg) and mixture 1 (21.7 mg). Mixture 2 (145.3 mg) was obtained from fraction MD2-4 by a silica gel column (9:1 (v/v) n-hexane: acetone as the eluent). Fraction MD3 was purified on a Sephadex LH-20 column eluted by CHCl 3 : MeOH (1:1) to afford 5 (15.2 mg) . Fraction MD4 was fractionated over a silica gel column and eluted by a n-hexane: EtOAc gradient (70:30 to 0:100 (v/v)) to afford seven sub-fractions (MD4-1 to MD4-7). Fraction MD4-5 was purified by a silica gel column eluted by n-hexane: CH 2 Cl 2 : MeOH gradient (3:3:0 to 3:6:1 (v/v)) to give mixture 6 (185.8 mg). Fraction MD4-7 was separated on a Sephadex LH-20 column (1:1 (v/v) CHCl 3 :MeOH as the eluent) and then applied to a silica gel eluted by 4:1 (v/v) n-hexane:acetone to furnish 7 (42.7 mg). 
Mixture 1: charantadiol A (1a) and epicharantadiol
HPLC analysis for mixtures 1 and 2:
Semi-preparative HPLC was performed on a ACE  5 C18-AR column (150  4.6 mm i.d., particle size 5 m). Mixture 1 was analyzed and separated with a gradient elution of 50% MeOH to 95% MeOH within 20 min and subsequent washing of the column with MeOH at a flow rate 1.0 mL/min. Peaks were detected by a UV detector at 230 nm. Two peaks of mixture 1 were observed at t R 27.6 and 28.1 min. Mixture 2 was analyzed and separated with an isocratic elution of 95% MeOH and two peaks were observed at t R 34.1 and 37.7 min.
X-ray crystallographic analysis of mixture 1:
X-ray crystallographic data of mixture 1 were collected at 296(2) K on a Bruker X8 APEX II KAPPA CCD diffractometer using graphite monochromatized Mo-K radiation ( = 0.71073 Å) by Assoc.
Prof. Thammarat Aree, Faculty of Science, Chulalongkorn University. A total of 12,093 collected data were merged, yielding 4,155 unique data. The crystal structure was solved by direct methods using SHELXS-97, expanded using the difference Fourier technique, and refined using full-matrix least squares on F 2 with SHELXL-97 [29] . The twofold disorder of the hydroxyl O-3H group on C-19 and the methylene C-26H 2 group on C-25 are restrained to normal bond distances of 1.42 and 1.32 Å, respectively. The atomic displacement parameters of sites A and B are modeled to have similar values for O-3H group, but those of C-26H 2 group are still different due to the tendency to move more. Atoms C-19 and C-25 with normal displacement parameters are well ordered and are not suggested for splitting during the structure refinement.
Crystals of mixture 1 belong to the monoclinic space group C2 (no. 5) with unit cell dimensions a = 17.5044(8), b = 11.8544(5), c = 12.6672(6) Å,  = 95.894(1), V = 2614.6(2) Å 3 , Z = 4, D calc = 1.155 g cm -3 , C 30 H 46 O 3 , MW= 454.67, F(000) = 1000. The final R 1 (F 2 ) = 0.066, wR(F 2 ) = 0.185 and GooF = 1.077 for 3,136 reflections with F 2 > 2(F 2 ). The absolute configuration of 1 could not be determined because no significant anomalous scattering atom present in the structure. Data have been deposited with the Cambridge Crystallographic Data Centre (CCDC 962174). Copies of these data can be obtained, free of charge, on application to the CCDC via www.ccdc.cam.ac.uk/conts/retrieving.html (or 12 Union Road, Cambridge CB2 1EZ, UK, fax: +44 1223 336033, e-mail: deposit@ccdc.cam.ac.uk).
Anti-cholinesterase (ChEI) assay:
All isolated compounds were preliminary screened for their ChEI activity at a final concentration of 0.5, 0.1 and 0.05 mg/mL. The assay was performed as described previously [30] . Due to the low solubility of the sample in this test condition, samples that showed a higher than 50% ChEI activity at a final concentration of 0.1 mg/mL were then used to determine their IC 50 values
